OBJECTIVE: To evaluate the correlation between stiffness values obtained by shear-wave elastography (SWE) and breast cancer subtypes. METHODS: This was an institutional review board-approved retrospective study with a waiver of informed consent. The stiffness of 337 invasive breast cancers in 337 women was evaluated by SWE and mean stiffness values (kPa) and qualitative colour scores (1-5) of tumours were obtained. The results were analysed according to BI-RADS category, tumour size, grade and tumour subtype (triple-negative [TN], human epidermal growth factor receptor 2 [HER2]-positive, and oestrogen receptor [ER]-positive) using a multiple linear regression analysis. RESULTS: The mean stiffness values and colour scores were: 146.8 kPa ± 57.0 and 4.1 ± 1.1; 165.8 kPa ± 48.5 and 4.6 ± 0.7 for TN tumours (n = 64), 160.3 kPa ± 56.2 and 4.3 ± 1.0 for HER2-positive tumours (n = 55) and 136.9 kPa ± 57.2 and 4.0 ± 1.1 for ER-positive tumours (n = 218; P < 0.0001). All three breast cancers classified as BI-RADS category 3 on B-mode ultrasound were TN subtype. A multiple linear regression analysis revealed that tumour size, histological grade and tumour subtype were independent factors that influenced the stiffness values. CONCLUSION: High stiffness values correlated with aggressive subtypes of breast cancer. KEY POINTS: • Shear-wave elastography is increasingly used to measure the stiffness of breast tumours. • Triple-negative and HER2-positive tumours showed greater stiffness than ER-positive tumours. • All breast cancers classified as BI-RADS 3 on B-mode ultrasound were triple-negative subtype. • Tumour size, histological grade and subtype were independent factors influencing SWE stiffness.
OBJECTIVE: To evaluate the correlation between stiffness values obtained by shear-wave elastography (SWE) and breast cancer subtypes. METHODS: This was an institutional review board-approved retrospective study with a waiver of informed consent. The stiffness of 337 invasive breast cancers in 337 women was evaluated by SWE and mean stiffness values (kPa) and qualitative colour scores (1-5) of tumours were obtained. The results were analysed according to BI-RADS category, tumour size, grade and tumour subtype (triple-negative [TN], human epidermal growth factor receptor 2 [HER2]-positive, and oestrogen receptor [ER]-positive) using a multiple linear regression analysis. RESULTS: The mean stiffness values and colour scores were: 146.8 kPa ± 57.0 and 4.1 ± 1.1; 165.8 kPa ± 48.5 and 4.6 ± 0.7 for TN tumours (n = 64), 160.3 kPa ± 56.2 and 4.3 ± 1.0 for HER2-positive tumours (n = 55) and 136.9 kPa ± 57.2 and 4.0 ± 1.1 for ER-positive tumours (n = 218; P < 0.0001). All three breast cancers classified as BI-RADS category 3 on B-mode ultrasound were TN subtype. A multiple linear regression analysis revealed that tumour size, histological grade and tumour subtype were independent factors that influenced the stiffness values. CONCLUSION: High stiffness values correlated with aggressive subtypes of breast cancer. KEY POINTS: • Shear-wave elastography is increasingly used to measure the stiffness of breast tumours. • Triple-negative and HER2-positive tumours showed greater stiffness than ER-positive tumours. • All breast cancers classified as BI-RADS 3 on B-mode ultrasound were triple-negative subtype. • Tumour size, histological grade and subtype were independent factors influencing SWE stiffness.
Authors: Wendie A Berg; David O Cosgrove; Caroline J Doré; Fritz K W Schäfer; William E Svensson; Regina J Hooley; Ralf Ohlinger; Ellen B Mendelson; Catherine Balu-Maestro; Martina Locatelli; Christophe Tourasse; Barbara C Cavanaugh; Valérie Juhan; A Thomas Stavros; Anne Tardivon; Joel Gay; Jean-Pierre Henry; Claude Cohen-Bacrie Journal: Radiology Date: 2012-02 Impact factor: 11.105
Authors: C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein Journal: Nature Date: 2000-08-17 Impact factor: 49.962
Authors: Lauriane Jugé; Bich-Thuy Doan; Johanne Seguin; Miguel Albuquerque; Benoît Larrat; Nathalie Mignet; Guy G Chabot; Daniel Scherman; Valérie Paradis; Valérie Vilgrain; Bernard E Van Beers; Ralph Sinkus Journal: Radiology Date: 2012-06-12 Impact factor: 11.105
Authors: Alfonso Sánchez-Muñoz; Ana María García-Tapiador; Esther Martínez-Ortega; Rosario Dueñas-García; Ana Jaén-Morago; Ana Laura Ortega-Granados; Mónica Fernández-Navarro; Capilla de la Torre-Cabrera; Basilio Dueñas; Ana Isabel Rueda; Francisco Morales; César Ramírez-Torosa; María Dolores Martín-Salvago; Pedro Sánchez-Rovira Journal: Clin Transl Oncol Date: 2008-10 Impact factor: 3.405
Authors: Andrew Evans; Patsy Whelehan; Kim Thomson; Denis McLean; Katrin Brauer; Colin Purdie; Lee Jordan; Lee Baker; Alastair Thompson Journal: Breast Cancer Res Date: 2010-12-01 Impact factor: 6.466
Authors: Stefan A Carp; Amir Y Sajjadi; Christy M Wanyo; Qianqian Fang; Michelle C Specht; Lidia Schapira; Beverly Moy; Aditya Bardia; David A Boas; Steven J Isakoff Journal: Biomed Opt Express Date: 2013-11-22 Impact factor: 3.732
Authors: S J Vinnicombe; P Whelehan; K Thomson; D McLean; C A Purdie; L B Jordan; S Hubbard; A J Evans Journal: Eur Radiol Date: 2013-12-11 Impact factor: 5.315